[225Ac]Ac-A9-3408

N/A

Report date: 2025/12/18 17:03:58

NME

Base Information

Drug Name[225Ac]Ac-A9-3408

Drug Alias Name[225Ac]Ac-A9-3408

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225Ac +[4]

Mechanisms of ActionPositron-emission tomography enhancersMelanocortin receptor 1 modulators

TargetsMelanocortin receptor 1

Therapy Area/IndicationsUveal melanomaMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAlpha-9 Oncology USA Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlpha-9 Oncology USA Inc

Inactive CompaniesN/A

Active IndicationsUveal melanomaMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A